bpc 157 human clinical trials knee pain Heal or Harm: Body Protective Compound-157 in the Gray Zone BPC-157 Human Trial: 87.5% of
Description
Its a direct consequence of this angiogenic effect

A batch that is 99% pure but incorrectly synthesized will show high HPLC purity while delivering zero biological activity

Nitric oxide production is known to play an important role on mediating angiogenesis 26

Facet joint injections aim to reduce this inflammation and ease pain
